Matthias Ocker, M.D.
Matthias brings more than 20 years of academic and industry experience in oncology and GI diseases at Bayer and at Boehringer Ingelheim. He held global senior positions in early drug development with a strong focus on biomarkers, translational medicine and clinical pharmacology. Matthias has led several programs into Phase 1 and to proof of concept and was a member of global portfolio steering committees. He has authored more than 130 scientific publications and book chapters and is a member of several academic societies like AACR and EASL.
Matthias received his M.D. from Friedrich-Alexander-University Erlangen-Nuremberg, Germany, and is a faculty member and adjunct professor of experimental medicine at Charité University Medicine Berlin, Germany.